Seeking Reimbursement for AI Tech? Five Things to Remember

article image
ARTICLE SUMMARY:

Devices driven by artificial intelligence algorithms are becoming more prevalent in healthcare, but reimbursement remains a challenge. Deborah Godes from McDermott+Consulting spoke to Market Pathways on the topic, offering insights for companies entering the coverage, coding, and payment trenches for AI tech in the latest "From the Experts" column.

AI-driven technologies such as imaging analysis algorithms are increasingly making their way through FDA review and edging into clinical practice, but for clinicians to leverage AI more routinely, the tools must be integrated and appropriately valued within the reimbursement system. 

×

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?


Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.

All-Access

Questions?

We're here to help! Please contact us at: